Last updated 2026-07-30
TL;DR
For men who want higher testosterone without shutting down sperm production, enclomiphene is often worth it, but it's compounded (not FDA-approved), costs roughly $100-250/month out of pocket, and works better for secondary hypogonadism than primary testicular failure. If fertility isn't a concern, TRT is cheaper, better studied, and more predictable.
What exactly is enclomiphene, and how is it different from clomiphene?
Enclomiphene is one of two isomers that make up clomiphene citrate (the drug sold for decades as Clomid). Clomiphene is actually a mixture of two mirror-image molecules: enclomiphene and zuclomiphene. Enclomiphene is the trans-isomer and does most of the testosterone-raising work by blocking estrogen receptors in the hypothalamus, which tricks your brain into thinking estrogen is low. That triggers more GnRH, more LH and FSH, and more signal to the testes to make testosterone and sperm. Zuclomiphene, the other isomer in clomiphene, has a much longer half-life (it can persist for weeks) and is weakly estrogenic. Some researchers think it's responsible for a chunk of the side effects people associate with clomiphene, like mood changes and visual disturbances, though the evidence isolating zuclomiphene's specific role is still thin [1]. So enclomiphene is not clomiphene's cousin. It's literally half of clomiphene, purified out. That's the whole pitch: same mechanism, theoretically cleaner side effect profile, without the estrogenic isomer along for the ride.
Is enclomiphene FDA-approved, or is it something else entirely?
No, enclomiphene is not FDA-approved as a standalone drug. This is the single most important fact to know before you spend money on it. A company called Repros Therapeutics developed enclomiphene citrate under the brand name Androxal and ran it through Phase 3 trials for secondary hypogonadism in men. The program never reached FDA approval. Repros discontinued its enclomiphene program years ago, and no manufacturer currently holds FDA approval for enclomiphene as a marketed product [2]. What you can actually buy today is compounded enclomiphene, made by compounding pharmacies under a prescription, using the same active pharmaceutical ingredient studied in those trials. Compounded drugs are legal to prescribe under specific FDA and state board of pharmacy frameworks (largely Section 503A of the Federal Food, Drug, and Cosmetic Act), but they are not FDA-reviewed for safety and efficacy the way an approved drug is [3]. That means no FDA-verified manufacturing standard applies uniformly, potency can vary between pharmacies, and you're relying on the prescribing clinic and the specific pharmacy's quality practices rather than an FDA approval letter. This isn't automatically disqualifying. Compounded testosterone, compounded hormone creams, and plenty of other compounded drugs are prescribed every day. But it does mean 'is enclomiphene worth it' has to include 'worth it, sourced from where, and regulated how' as part of the answer.
Does enclomiphene actually preserve fertility better than TRT?
This is the real reason most men look at enclomiphene instead of injectable testosterone, and the evidence here is genuinely more favorable than the FDA-approval story. Exogenous testosterone (TRT) suppresses the hypothalamic-pituitary-gonadal axis. Your brain senses plenty of testosterone already circulating, so it stops sending LH and FSH signals to the testes. No LH/FSH signal means the testes stop or drastically slow sperm production and often shrink in size. This is well documented: studies on TRT-induced azoospermia show sperm counts can drop to zero within months of starting testosterone therapy, and recovery, when it happens, can take many months to over a year [4]. Enclomiphene works upstream of that problem. Because it raises testosterone by increasing your own LH and FSH output rather than replacing testosterone from outside, it keeps the signal to the testes intact. Multiple clinical studies of enclomiphene (including the Phase 3 Androxal trials) found it raised total testosterone into the normal range while maintaining or only minimally affecting sperm parameters and LH/FSH levels, in contrast to testosterone gel comparators which suppressed both [5]. Here's the honest caveat: 'preserves fertility' is not the same as 'guarantees fertility' or 'improves sperm count.' Most enclomiphene trials measured testosterone, LH, and FSH as primary endpoints, not live birth rates or pregnancy outcomes. If you have a specific fertility goal (trying to conceive in the next year, for example), the data support enclomiphene as the more fertility-conscious choice among testosterone-raising options, but nobody should promise you a baby because of it. Talk to a reproductive urologist if fertility timing actually matters, more than a TRT clinic. For a closer look at what results actually look like over time, see enclomiphene results timeline and enclomiphene before and after.
Does enclomiphene work as well as TRT for raising testosterone?
In the populations studied, yes, roughly comparably, but with an important caveat about who it works for. Enclomiphene depends on a functioning pituitary and functioning testes. It's essentially telling your own machinery to make more testosterone. That means it works best for secondary hypogonadism (low T caused by a pituitary/hypothalamic signaling problem, common in overweight or older men) and works poorly or not at all for primary hypogonadism (testicular failure, like from a genetic condition, chemotherapy, or testicular injury), because in that scenario the testes can't respond to more LH/FSH signal no matter how strong the signal gets. In the Phase 3 Androxal trials for secondary hypogonadism, enclomiphene restored testosterone to the normal range (300-1000 ng/dL by common lab reference ranges) in a majority of treated men over 3 to 6 months, performing comparably to topical testosterone gel on the testosterone-normalization endpoint while better preserving sperm concentration [5]. That's a meaningfully different profile than testosterone injections, which reliably normalize testosterone regardless of the underlying cause, because they bypass the axis entirely. So 'does it work as well as TRT' really splits into two questions. For raising the number on a lab report in men with secondary hypogonadism, the data say it's roughly comparable. For men with primary testicular failure, TRT works and enclomiphene largely doesn't, because there's no functioning testis to stimulate.
What does enclomiphene actually cost, and is that a good deal?
| Compounded enclomiphene | $100-250 | Not approved (compounded) | Generally preserved in trials | |
|---|---|---|---|---|
| Generic clomiphene (off-label) | $15-40 | Approved (for a different indication) | Preserved, but zuclomiphene may add side effects | |
| Testosterone cypionate injection | $20-60 (drug only) | Approved | Suppressed, often significantly | |
| Testosterone gel (branded) | $200-500+ | Approved | Suppressed | So on cost alone, enclomiphene is not the cheap option. It sits in the middle, more expensive than generic clomiphene, often cheaper than branded TRT gels, and roughly in the same range as generic testosterone injections once clinic fees are included. |
Expect somewhere in the range of $100 to $250 per month for compounded enclomiphene, depending on dose, pharmacy, and whether it's bundled into a telehealth subscription that includes bloodwork and provider visits. This is not an FDA-listed drug with a standardized price, so quotes vary a lot between clinics and compounding pharmacies, and there's no single authoritative price index to cite here (a genuine limitation in the data, not something to paper over). Compare that to generic clomiphene citrate, which is FDA-approved (for female infertility, prescribed off-label for men) and can cost as little as $15 to $40 per month at a retail pharmacy using a GoodRx-type discount, because it's a decades-old generic. Some men and their doctors choose off-label clomiphene specifically because it's cheaper and FDA-approved, accepting the extra zuclomiphene along for the ride. TRT itself ranges widely too: generic testosterone cypionate injections can run $20 to $60 a month in supply cost, though clinic membership fees, needles, and monitoring bloodwork add to that. Testosterone gels and branded formulations cost considerably more, often $200 to $500+ a month, especially before insurance. | Option | Typical monthly cost | FDA status | Fertility impact |
What are the real downsides and side effects?
The side effect profile reported in enclomiphene trials includes headache, nausea, and in a minority of men, mood changes, though these were generally reported at low rates in the Phase 3 program submitted for Androxal [5]. Because it raises LH and FSH, some men see a temporary increase in estrogen (estradiol) as a downstream effect of higher testosterone, which occasionally needs separate management. Because it's compounded, you also carry sourcing risk that FDA-approved drugs don't have. Potency can differ pharmacy to pharmacy. There's no FDA post-market surveillance database tracking adverse events for compounded enclomiphene the way there is for approved drugs through the FDA Adverse Event Reporting System. If something goes wrong, you're relying on your prescriber's judgment and the compounding pharmacy's quality control, not an FDA-reviewed label. There's also a subgroup for whom it simply doesn't work well: men with primary hypogonadism (as covered above), and some men who just don't respond as well to SERMs for reasons that aren't fully understood, sometimes related to estrogen receptor sensitivity or baseline pituitary reserve. If you don't respond within 2-3 months on bloodwork, that's a signal to reassess rather than keep pushing, per how the drug's mechanism actually works. For a fuller breakdown, enclomiphene pros and cons covers the tradeoffs in more depth, and enclomiphene first month what to expect is useful if you want to know what the early weeks actually feel like before committing.
Who is enclomiphene actually worth it for?
Based on the mechanism and the trial data, enclomiphene tends to make the most sense for a specific kind of patient, not everyone with low testosterone on a lab report. It's generally worth considering if you have secondary hypogonadism (confirmed by bloodwork showing low testosterone with low-to-normal LH/FSH, not high LH/FSH which points to primary failure), you want to preserve fertility or testicular size, and you're either actively trying to conceive or just don't want the shutdown that comes with injections. It also fits men who tried TRT, didn't like the shutdown or the injection routine, and want to explore whether their own axis can be coaxed back into normal range instead. It's probably not worth it if you have primary hypogonadism (the testes themselves aren't functioning, so stimulating LH/FSH more won't help), you want the fastest, most predictable testosterone normalization regardless of fertility, or budget is the primary driver and off-label generic clomiphene is an acceptable substitute for you and your doctor. One more honest point: 'worth it' also depends on whether you can find a prescriber who actually knows the drug, orders the right monitoring labs (total and free testosterone, LH, FSH, estradiol at minimum), and follows up. A lot of the disappointment men report with enclomiphene traces back to poor monitoring or unrealistic expectations rather than the drug itself. Real-world experiences vary; see enclomiphene reviews and enclomiphene success rate for how outcomes actually break down across different starting points.
How do you actually get enclomiphene, and does sourcing matter?
Since there's no FDA-approved commercial product, you need a prescriber willing to order it from a compounding pharmacy. That's typically a telehealth men's health clinic, a urologist, or an endocrinologist who is comfortable with off-label and compounded prescribing. Sourcing matters more here than with a standard generic, precisely because there's no FDA approval standardizing potency and manufacturing. A provider-reviewed pathway, meaning your labs are actually reviewed by a licensed prescriber before and during treatment, and the prescription is filled by a named, accountable compounding pharmacy rather than an anonymous overseas supplier, is the difference between a legitimate medical treatment and a gray-market gamble. Enclomiphene Direct works this way: prescriptions are provider-reviewed and filled through its fulfilling pharmacy partner, not compounded or manufactured by the brand itself. Whatever route you use, don't skip baseline labs (total testosterone, free testosterone, LH, FSH, estradiol, and a semen analysis if fertility matters to you) and don't skip the follow-up labs at 6-8 weeks. Buying enclomiphene from a research-chemical website with no prescription and no monitoring is a different risk category entirely, and not one this article can responsibly call 'worth it' at any price.
Enclomiphene vs TRT: the real tradeoff, side by side
| FDA approval | Not approved (compounded only) | Approved (multiple formulations) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Works for primary hypogonadism | Generally no | Yes | |||||||||
| Works for secondary hypogonadism | Yes, comparable to gel in trials [5] | Yes | |||||||||
| Fertility/sperm production | Generally preserved [5] | Often suppressed [4] | |||||||||
| Testicular size | Maintained | Can shrink | |||||||||
| Monthly cost | ~$100-250 | ~$20-500+ depending on formulation | Administration | Oral tablet | Injection, gel, pellet | Long-term outcome data | Limited (trials mostly 3-6 months) | Decades of data | The honest summary: TRT has more approval status and more long-term data behind it, but it costs fertility for most men who use it. Enclomiphene has a narrower approved evidence base (none of it FDA-approved, all from a discontinued drug program) but a genuinely better fertility-preservation signal in the studies that exist. Which one is 'worth it' depends entirely on whether preserving your ability to have kids while treating low T outweighs wanting an approved product with a longer track record. |
Every version of 'is X worth it' eventually comes down to what you're optimizing for. Here's the tradeoff stripped down. | Factor | Enclomiphene | Testosterone (TRT) |
Frequently asked questions
Is enclomiphene FDA-approved?
No. Enclomiphene was developed as Androxal by Repros Therapeutics and went through Phase 3 trials for male secondary hypogonadism, but the program was discontinued and never reached FDA approval. What's available today is compounded enclomiphene, prescribed off a legal compounding framework, not an FDA-reviewed commercial product.
Is enclomiphene better than clomiphene?
Enclomiphene is one of clomiphene's two isomers, the one that does most of the testosterone-raising work. Clomiphene also contains zuclomiphene, a long-lasting, weakly estrogenic isomer some researchers link to more side effects. Enclomiphene may have a cleaner side effect profile, but generic clomiphene is FDA-approved and much cheaper, so some doctors still prefer it.
Does enclomiphene really preserve fertility better than TRT?
In the clinical trials that exist, yes: enclomiphene largely maintained LH, FSH, and sperm parameters while testosterone gel comparators suppressed them. But 'preserves fertility' isn't the same as 'guarantees a pregnancy.' Most trials measured hormone levels, not conception rates, so treat this as a meaningfully better signal, not a promise.
How much does enclomiphene cost per month?
Compounded enclomiphene typically runs $100 to $250 a month, depending on dose, the prescribing clinic, and whether bloodwork and visits are bundled in. There's no standardized retail price because it isn't FDA-approved, so quotes vary meaningfully between telehealth clinics and compounding pharmacies.
Does enclomiphene work for everyone with low testosterone?
No. It works best for secondary hypogonadism, where the pituitary and testes are intact but under-signaled. It generally doesn't work for primary hypogonadism (testicular failure), because there's no functioning testis left to respond to the extra LH/FSH signal enclomiphene generates.
What are the main side effects of enclomiphene?
Trial data report headache, nausea, and occasional mood changes at generally low rates. Because it raises LH and FSH, estradiol can also rise as testosterone rises, which sometimes needs its own management. Compounded sourcing adds a separate risk: potency isn't standardized the way an FDA-approved drug's is.
Is compounded enclomiphene safe?
It can be, when prescribed by a licensed provider and filled by an accountable, quality-controlled compounding pharmacy, under the legal framework in Section 503A of the Food, Drug, and Cosmetic Act. It carries more sourcing uncertainty than an FDA-approved drug though, since potency and manufacturing aren't FDA-reviewed.
How long does it take to see results from enclomiphene?
Most clinical protocols check labs at 4-8 weeks and expect meaningful testosterone changes by then, with fuller effects assessed around 3 months. Individual response varies with baseline hormone levels and dose. If bloodwork shows no real movement by 8-12 weeks, that's usually a sign to reassess, not push through.
Is enclomiphene cheaper than TRT?
Not necessarily. Generic testosterone cypionate injections can cost less per month in raw drug cost ($20-60) than compounded enclomiphene ($100-250), though clinic fees narrow that gap. Branded TRT gels usually cost more than enclomiphene. Generic off-label clomiphene is the cheapest testosterone-and-fertility option overall.
Can you take enclomiphene while trying to conceive?
Some fertility-focused prescribers use enclomiphene or clomiphene specifically in men trying to conceive, because it raises testosterone without suppressing sperm production the way TRT does. It's not an FDA-approved fertility treatment, and if conception timing matters, involve a reproductive urologist alongside whoever prescribes it.
What happens to testicular size on enclomiphene versus TRT?
TRT commonly causes testicular shrinkage over months, because suppressed LH/FSH signaling reduces the testes' own hormone and sperm production workload. Enclomiphene trials generally showed maintained testicular function and size, since it works by increasing, not replacing, the natural LH/FSH signal.
Is enclomiphene worth it if I already tried TRT and disliked it?
It's a reasonable next step to discuss with your doctor, especially if fertility, testicular size, or injection frequency were the issues with TRT. It works best if bloodwork shows secondary hypogonadism rather than primary testicular failure, so get LH and FSH checked before switching.
Sources
- PubMed - Clomiphene citrate isomers and male reproductive function: Clomiphene is a mixture of enclomiphene and zuclomiphene isomers, with zuclomiphene having a much longer half-life and weak estrogenic activity
- ClinicalTrials.gov - Androxal (enclomiphene citrate) Phase 3 program record: Enclomiphene citrate (Androxal) underwent Phase 3 trials for secondary hypogonadism but the development program was discontinued without FDA approval
- FDA - Human Drug Compounding under Section 503A: Compounded drugs, including compounded enclomiphene, are prepared under Section 503A of the Federal Food, Drug, and Cosmetic Act and are not FDA-reviewed for safety and efficacy the way approved drugs are
- NIH/NCBI - Testosterone therapy and male fertility suppression: Exogenous testosterone therapy suppresses the hypothalamic-pituitary-gonadal axis and commonly leads to significantly reduced or absent sperm production
- Journal of Sexual Medicine - Enclomiphene citrate Phase 3 trial results in men with secondary hypogonadism: Enclomiphene citrate normalized testosterone comparably to testosterone gel while better preserving sperm concentration and LH/FSH levels in Phase 3 trials